Publications by authors named "Valery Fikkert"

Claim this Profile
D
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.
Laith Q Al-Mawsawi, Valery Fikkert, Raveendra Dayam, Myriam Witvrouw, Terrence R Burke

Proc Natl Acad Sci U S A· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology.
Anke Hantson, Valery Fikkert, Barbara Van Remoortel, Chistophe Pannecouque, Peter Cherepanov

Antivir Chem Chemother· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
Myriam Witvrouw, Valery Fikkert, Anke Hantson, Christophe Pannecouque, Barry R O'keefe

J Virol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360.
Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, Marc De Maeyer, Christophe Pannecouque

AIDS· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations.
Valery Fikkert, Bénédicte Van Maele, Jo Vercammen, Anke Hantson, Barbara Van Remoortel

J Virol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry.
Myriam Witvrouw, Christophe Pannecouque, Valery Fikkert, Anke Hantson, Barbara Van Remoortel

Antivir Chem Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors.
Valery Fikkert, Peter Cherepanov, Kristel Van Laethem, Anke Hantson, Barbara Van Remoortel

Antimicrob Agents Chemother· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives.
Wim Pluymers, Godwin Pais, Bénédicte Van Maele, Christophe Pannecouque, Valery Fikkert

Antimicrob Agents Chemother· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis